These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
616 related articles for article (PubMed ID: 32546241)
1. Regulation of Hippo-YAP signaling by insulin-like growth factor-1 receptor in the tumorigenesis of diffuse large B-cell lymphoma. Zhou X; Chen N; Xu H; Zhou X; Wang J; Fang X; Zhang Y; Li Y; Yang J; Wang X J Hematol Oncol; 2020 Jun; 13(1):77. PubMed ID: 32546241 [TBL] [Abstract][Full Text] [Related]
2. Klotho, an anti-aging gene, acts as a tumor suppressor and inhibitor of IGF-1R signaling in diffuse large B cell lymphoma. Zhou X; Fang X; Jiang Y; Geng L; Li X; Li Y; Lu K; Li P; Lv X; Wang X J Hematol Oncol; 2017 Feb; 10(1):37. PubMed ID: 28153033 [TBL] [Abstract][Full Text] [Related]
3. Picropodophyllin inhibits proliferation and survival of diffuse large B-cell lymphoma cells. Strömberg T; Feng X; Delforoush M; Berglund M; Lin Y; Axelson M; Larsson O; Georgii-Hemming P; Lennartsson J; Enblad G Med Oncol; 2015 Jul; 32(7):188. PubMed ID: 26021470 [TBL] [Abstract][Full Text] [Related]
4. GPNMB promotes the progression of diffuse large B cell lymphoma via YAP1-mediated activation of the Wnt/β-catenin signaling pathway. Wang Z; Ran X; Qian S; Hou H; Dong M; Wu S; Ding M; Zhang Y; Zhang X; Zhang M; Chen Q Arch Biochem Biophys; 2021 Oct; 710():108998. PubMed ID: 34280359 [TBL] [Abstract][Full Text] [Related]
5. KIAA1429-mediated m6A modification of CHST11 promotes progression of diffuse large B-cell lymphoma by regulating Hippo-YAP pathway. Chen X; Lu T; Cai Y; Han Y; Ding M; Chu Y; Zhou X; Wang X Cell Mol Biol Lett; 2023 Apr; 28(1):32. PubMed ID: 37076815 [TBL] [Abstract][Full Text] [Related]
6. Control of apoptosis in human multiple myeloma by insulin-like growth factor I (IGF-I). Jernberg-Wiklund H; Nilsson K Adv Cancer Res; 2007; 97():139-65. PubMed ID: 17419944 [TBL] [Abstract][Full Text] [Related]
7. Activated hippo signal pathway inhibits cell proliferation and promotes apoptosis in NK/T cell lymphoma cells. Chang Y; Fu XR; Cui M; Li WM; Zhang L; Li X; Li L; Sun ZC; Zhang XD; Li ZM; You XY; Nan FF; Wu JJ; Wang XH; Zhang MZ Cancer Med; 2019 Jul; 8(8):3892-3904. PubMed ID: 31124291 [TBL] [Abstract][Full Text] [Related]
8. Platelet‑derived growth factor‑BB mediates pancreatic cancer malignancy via regulation of the Hippo/Yes‑associated protein signaling pathway. Li T; Guo T; Liu H; Jiang H; Wang Y Oncol Rep; 2021 Jan; 45(1):83-94. PubMed ID: 33416116 [TBL] [Abstract][Full Text] [Related]
9. The Hippo Pathway and YAP Signaling: Emerging Concepts in Regulation, Signaling, and Experimental Targeting Strategies With Implications for Hepatobiliary Malignancies. Werneburg N; Gores GJ; Smoot RL Gene Expr; 2020 Jun; 20(1):67-74. PubMed ID: 31253203 [TBL] [Abstract][Full Text] [Related]
10. YAP promotes breast cell proliferation and survival partially through stabilizing the KLF5 transcription factor. Zhi X; Zhao D; Zhou Z; Liu R; Chen C Am J Pathol; 2012 Jun; 180(6):2452-61. PubMed ID: 22632819 [TBL] [Abstract][Full Text] [Related]
11. Verteporfin inhibits YAP-induced bladder cancer cell growth and invasion via Hippo signaling pathway. Dong L; Lin F; Wu W; Liu Y; Huang W Int J Med Sci; 2018; 15(6):645-652. PubMed ID: 29725256 [TBL] [Abstract][Full Text] [Related]
12. AMOTL1 enhances YAP1 stability and promotes YAP1-driven gastric oncogenesis. Zhou Y; Zhang J; Li H; Huang T; Wong CC; Wu F; Wu M; Weng N; Liu L; Cheng ASL; Yu J; Wong N; Lo KW; Tang PMK; Kang W; To KF Oncogene; 2020 May; 39(22):4375-4389. PubMed ID: 32313226 [TBL] [Abstract][Full Text] [Related]
13. ZNF213 negatively controls triple negative breast cancer progression via Hippo/YAP signaling. Liu Y; Su P; Zhao W; Li X; Yang X; Fan J; Yang H; Yan C; Mao L; Ding Y; Zhu J; Niu Z; Zhuang T Cancer Sci; 2021 Jul; 112(7):2714-2727. PubMed ID: 33939216 [TBL] [Abstract][Full Text] [Related]
14. Induction of store-operated calcium entry (SOCE) suppresses glioblastoma growth by inhibiting the Hippo pathway transcriptional coactivators YAP/TAZ. Liu Z; Wei Y; Zhang L; Yee PP; Johnson M; Zhang X; Gulley M; Atkinson JM; Trebak M; Wang HG; Li W Oncogene; 2019 Jan; 38(1):120-139. PubMed ID: 30082911 [TBL] [Abstract][Full Text] [Related]
15. The expression and significance of insulin-like growth factor-1 receptor and its pathway on breast cancer stem/progenitors. Chang WW; Lin RJ; Yu J; Chang WY; Fu CH; Lai A; Yu JC; Yu AL Breast Cancer Res; 2013 May; 15(3):R39. PubMed ID: 23663564 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of Polo-like kinase 4 induces mitotic defects and DNA damage in diffuse large B-cell lymphoma. Zhao Y; Yang J; Liu J; Cai Y; Han Y; Hu S; Ren S; Zhou X; Wang X Cell Death Dis; 2021 Jun; 12(7):640. PubMed ID: 34162828 [TBL] [Abstract][Full Text] [Related]
17. Evodiamine inhibits proliferation and promotes apoptosis of hepatocellular carcinoma cells via the Hippo-Yes-Associated Protein signaling pathway. Zhao S; Xu K; Jiang R; Li DY; Guo XX; Zhou P; Tang JF; Li LS; Zeng D; Hu L; Ran JH; Li J; Chen DL Life Sci; 2020 Jun; 251():117424. PubMed ID: 32057900 [TBL] [Abstract][Full Text] [Related]